How to beat the COVID-19 cost surge: Strategies to improve population health and mitigate cost increases

As COVID-19 cases continue to rise in a number of states, planning for what lurks ahead for employer health care costs is increasingly challenging. Estimates for treating COVID- related costs range from $50 billion to $550 billion over the next 2 years - a tenfold swing!

Join us for a discussion on budgeting and setting rates for 2021, cost mitigation strategies, and trend management for self-insured health plans.

Register to watch the on-demand webinar _»

To help you manage this unprecedented volatility, our speakers will share targeted actions to help employers address deferred care, specialty prescriptions, and more. They'll also discuss the “unlucky” seven trend components and how each integrates into our rate/trend modeler:

Base medical/Rx trend
Direct COVID-19 cost
Long-term COVID-19 complications
Unit cost increases
Uptick in behavioral health claims
Additional high-cost claims
Completion of deferred care

About our speakers

Kelly Conlin | Kelly is a Principal and serves as Buck's Chief Actuary and Regional Leader for the Health practice. Kelly manages Buck’s national health actuarial team and is as a consultant for a variety of international, public sector, multi-employer, and corporate clients.

David Foster | David is a Principal in the Health practice and the Core COE leader. David participates in a broad range of health care and group benefit issues with emphasis in the evaluation, design, implementation, and performance management of life, health, and disability programs and services.